Board of Directors

Bill Ericson

Mr. Ericson joined Mohr Davidow Ventures in 2000. As a managing partner, his investment focus is life sciences and software. He works closely with a cross-disciplinary team of leading scientists, researchers and entrepreneurs applying technology solutions to life sciences and health care in non-traditional ways. Mr. Ericson came to MDV after 10 years of working with and investing in entrepreneurs and early-stage companies. During that time, he served as a board member of a number of life sciences and software companies, both public and private. He was a member of the founding team of Rosetta Inpharmatics and served on the Board of Directors until its acquisition by Merck in 2001.